←

ELV · Elevance Health, Inc.

Healthcare NYQ United States elevancehealth.com ↗
Val — — Gro — — Qua — — Mom — — Sta — — Cap— P/S0.45 P/E— Fwd P/E13.68 PEG1.29 52W— – — RSI— Target$482.38 (+16.4%) Beta0.71 Div1.63%
Loading chart…
RSI ()
◈ Pattern Overlays
Loading patterns…
Healthcare Plans Indianapolis, United States 96,129 employees
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low — 52W High
Position in Range —
RSI (14)
0 · Oversold RSI 47 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
5Bullish
5Bearish
0Neutral

Key Signals 1

▼ Double Top Major reversal 2026-09-30 · $390.8
Two peaks ~$418.73 — bearish reversal confirmed
Learn more →

Momentum Signals 9

▲ MACD Bullish Crossover 2026-07-02 · $417.89
▲ MACD Bullish Crossover 2026-08-06 · $391.4
▲ MACD Bullish Crossover 2026-09-01 · $403.04
▲ MACD Bullish Crossover 2026-10-08 · $400.94

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Jan 28, 2027
Beat Rate 75%
Consensus BUY
Analyst Upside +16.4%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
75% 6/8 quarters
Wall Street Consensus
BUY
14
8
BuyHoldSell
Price Target Range
$482.38 +16.4% upside
Low $406 — High $523
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 26.43%Last 12 Months
Operating Margin 4.22%Last 12 Months
Return on Equity 11.48%Last 12 Months
Revenue Growth 1.40%Year over Year
Free Cash Flow 7.99BLast 12 Months
Free Cash Flow Yield —Last 12 Months
Balance Sheet
Debt / Equity 68.66Most Recent Quarter
Current Ratio 1.47Most Recent Quarter
Cash 37.85BMost Recent Quarter
Total Debt 30.76BMost Recent Quarter
Net Debt —Most Recent Quarter
How ELV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap89.87B
Enterprise Value82.56B
Trailing P/E17.90
Forward P/E13.68
PEG Ratio (5yr)1.29
Price/Sales (ttm)0.45
Price/Book (mrq)2.00
EV/Revenue0.41
EV/EBITDA9.47
Share Statistics
Avg Vol (3m)1.15M
Shares Outstanding216.87M
Float215.57M
% Held by Insiders0.18%
% Held by Institutions94.38%
Short Ratio4.04
Short % of Float2.65%
Profitability
Gross Margin26.43%
Operating Margin (ttm)4.22%
Profit Margin2.55%
Return on Assets (ttm)4.00%
Return on Equity (ttm)11.48%
Income Statement
Revenue (ttm)201.83B
Revenue Growth (yoy)1.40%
Gross Profit (ttm)53.35B
EBITDA8.71B
Net Income (ttm)5.14B
Diluted EPS (ttm)23.15
EPS Growth (yoy)17.90%
Balance Sheet
Total Cash (mrq)37.85B
Total Debt (mrq)30.76B
Debt / Equity (mrq)68.66
Current Ratio (mrq)1.47
Book Value / Share206.75
Operating CF (ttm)7.60B
Free Cash Flow (ttm)7.99B
Trading & Dividends
Beta (5Y)0.71
50-Day MA409.62
200-Day MA371.86
Fwd Dividend Yield1.63%
Payout Ratio29.17%
Income
Dividend Yield 1.63%Last 12 Months
Annual Rate 6.88Forward
Payout Ratio 29.17%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 29.17%
Monthly Dividends
Ownership Breakdown
Institutional 94.38% Insider 0.18% Public 5.4%
Short Interest 2.65% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in ELV in their latest SEC 13F filing.

Loading…
Insider Transactions
Open-market buys & sells · one dot per day, sized by $ · follows the filters below
Date Insider Role Transaction Shares Price Value